Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Acquisition

18 May 2017 07:00

RNS Number : 4793F
Marston's PLC
18 May 2017
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

18 May 2017

MARSTON'S PLC

Acquisition of Charles Wells Brewing and Beer Business for £55 million

Marston's PLC ("Marston's" or "the Group") today announces that it has agreed to acquire the Charles Wells brewing business from the Charles Wells Group for a cash consideration of £55 million, plus working capital adjustments.

Based in Bedford, Charles Wells Brewing and Beer Business is an established high quality brewing business with a portfolio of more than 30 beers including leading brands such as Bombardier, Young's and McEwan's. In addition, the business has UK distribution rights for the Estrella Damm lager brand and other beers under license including Kirin and Erdinger. As part of this acquisition, we have entered into a long-term exclusive agreement to supply all beer, wine, spirits and minerals to the Charles Wells pub estate. The brewery site, which is freehold, employs around 300 people.

The Charles Wells Brewing and Beer Business acquisition complements the existing Marston's Beer Company strategy:

· Extends our number 1 position in the premium bottled ale and cask ale markets, and enhances our share of the premium canned market.

· Strengthens our presence in London and the South East and presents a platform to expand into Scotland.

· Develops our licensed brands business.

· Expands our production capabilities to include lager brewing and canning, whilst improving production and distribution efficiency.

Furthermore, there is a strong financial rationale for the Charles Wells Brewing and Beer Business acquisition:

· Enterprise value of £55 million equates to 9x current EBITDA before synergies.

· Transaction to be funded through equity placing as announced today (see separate announcement).

· Expected synergies of £4 million to be achieved by financial year 2019.

· ROIC expected to exceed 18% in third full year.

 

Rationale for the Charles Wells acquisition

Marston's Beer Company ("MBC") has deployed a consistent strategy over the last five years to become the UK's leading premium beer business. Today, MBC has an experienced senior team and holds leading market share in both the premium bottled and premium cask ale markets. MBC takes a local approach to its brewing capabilities via its portfolio of five regional breweries located throughout England and has recently extended its focus to licensed brands, including Shipyard, which is now the number 2 Craft Beer in the UK, as well as the Warsteiner, Kruzovice and Kingstone Press brands.

MBC has also successfully enhanced shareholder value through acquisitions, most recently through the £25 million purchase of the Thwaites beer business in 2015. Since acquisition the Thwaites beer brands have performed strongly, delivering synergies in line with expectations and returns well in excess of the Group average.

Charles Wells Brewing and Beer Business presents an excellent opportunity which is consistent with our strategy. With a brand portfolio which will not only increase our ale market share from 11% to 16%, this acquisition will also strengthen our representation in London and the South East, and present an opportunity through the McEwan's brand to expand into Scotland. Charles Wells Brewing and Beer Business also brings with it significant expertise in licensed brands most notably its portfolio includes the growing Estrella Damm lager brand which represents a significant opportunity. From a supply chain perspective, Charles Wells offers lager brewing and canning capacity of scale, activities which are not currently undertaken by Marston's. In addition, the acquisition presents opportunities to further improve efficiencies in brewing, packaging and logistics.

Charles Wells Brewing and Beer Business financial profile

For the financial year ended 30 September 2016, Charles Wells Brewing and Beer Business generated revenues of £92 million, EBITDA of £6 million, operating EBIT of £5 million on a 52 week basis and net tangible assets of £36 million. Marston's estimates it can generate operational improvements similar to those achieved in previous acquisitions and has identified potential costs savings of £4 million by financial year 2019, with the majority being realised in financial year 2018.

Transaction details and timing

Marston's intends to finance the acquisition from the proceeds of an equity placing announced today, which represents 9.9% of Marston's issued share capital.

Completion of the acquisition is expected in June 2017, following completion of the appropriate consultation procedures.

Ralph Findlay, Chief Executive Officer of Marston's PLC, commented:

"We are delighted to have agreed to acquire Charles Wells Brewing and Beer Business. It is a high quality brewing business offering us opportunities to extend our trading area in the South of England and Scotland, and brings a range of well-known and popular brands into our portfolio. We also aim to develop further our range of international licensed brands, and look forward to working with our new overseas partners, including Estrella Damm, Erdinger and Kirin.

The acquisition of Charles Wells Brewing and Beer Business builds on Marston's established brewing prowess and is a further step in our objective to develop the leading premium beer business in the UK market. We have demonstrated our ability to acquire, integrate and develop beer brands evidenced by the success of brands such as Hobgoblin, Wainwright, and Lancaster Bomber. We have also achieved success with international licensed brands including Shipyard, now the 2nd biggest craft beer in the UK on trade."

Justin Phillimore, Chief Executive Officer of Charles Wells Brewery Limited, commented:

 

"We are delighted to have reached an agreement with Marston's to acquire our brewery and become a close trading partner. After a detailed review of our strategy we had decided to re-balance the company more towards retail investment and that meant finding a partner we could work with for the future. There are opportunities for both companies in this deal and we look forward to bringing them to life."

 

   

ENQUIRIES:

 

 

 

 

Marston's PLC

Tel: 020 7457 2020 (today)

01902 329516 (thereafter)

 

Instinctif Partners

Tel: 020 7457 2020

Ralph Findlay

Chief Executive Officer

Justine Warren

 

Andrew Andrea

Chief Financial and

Corporate Development Officer

Matthew Smallwood

 

      

 

Disclaimer

This announcement is not and does not contain an offer of securities for sale or a solicitation of an offer to purchase or subscribe for securities in the United States or any other state or jurisdiction in which it would be unlawful. The securities referred to in this announcement (the "Securities") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from, or a transaction not subject to, registration under the Securities Act.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFSDESIDLID
Date   Source Headline
2nd Feb 20152:53 pmRNSTotal Voting Rights
28th Jan 201511:59 amRNSResult of AGM
27th Jan 20157:00 amRNSAGM And Trading Statement
13th Jan 201510:09 amRNSBlocklisting Interim Review
6th Jan 20154:51 pmRNSHolding(s) in Company
2nd Jan 201510:37 amRNSTotal Voting Rights
24th Dec 201410:55 amRNSDirector/PDMR Shareholding
18th Dec 20141:46 pmRNSAnnual Financial Report
9th Dec 201410:07 amRNSHolding(s) in Company
1st Dec 20145:24 pmRNSTotal Voting Rights
27th Nov 20147:00 amRNSPreliminary Results
18th Nov 20145:41 pmRNSHolding(s) in Company
3rd Nov 20142:10 pmRNSTotal Voting Rights
8th Oct 20147:00 amRNSYear-end trading update
2nd Oct 201411:19 amRNSTotal Voting Rights
26th Sep 201411:00 amRNSHolding(s) in Company
18th Sep 20149:47 amRNSDirectorate Change
16th Sep 201410:01 amRNSHolding(s) in Company
10th Sep 20149:21 amRNSHolding(s) in Company
9th Sep 20144:51 pmRNSHolding(s) in Company
5th Sep 20147:00 amRNSBoard Appointments
1st Sep 20144:41 pmRNSTotal Voting Rights
1st Aug 20142:52 pmRNSTotal Voting Rights
24th Jul 20147:00 amRNSInterim Management Statement
21st Jul 201412:13 pmRNSHolding(s) in Company
10th Jul 20143:06 pmRNSBlocklisting Interim Review
4th Jul 201410:57 amRNSTotal Voting Rights
1st Jul 20143:56 pmRNSTotal Voting Rights
26th Jun 20143:01 pmRNSDirector/PDMR Shareholding
25th Jun 20142:22 pmRNSHolding(s) in Company
25th Jun 20141:40 pmRNSDirector/PDMR Shareholding
18th Jun 201410:29 amRNSDirector/PDMR Shareholding
3rd Jun 20143:22 pmRNSTotal Voting Rights
19th May 20144:34 pmRNSDirector/PDMR Shareholding
15th May 20147:00 amRNSInterim Results
1st May 20141:12 pmRNSTotal Voting Rights
1st Apr 201411:23 amRNSTotal Voting Rights
3rd Mar 20142:06 pmRNSTotal Voting Rights
28th Feb 201412:22 pmRNSDirector/PDMR Shareholding
27th Feb 201411:40 amRNSHolding(s) in Company
3rd Feb 20143:50 pmRNSTotal Voting Rights
21st Jan 20144:16 pmRNSResult of AGM
21st Jan 20147:00 amRNSAGM and Interim Management Statement
13th Jan 201410:13 amRNSBlocklisting Interim Review
6th Jan 201411:45 amRNSHolding(s) in Company
2nd Jan 20143:47 pmRNSTotal Voting Rights
17th Dec 20134:37 pmRNSAnnual Financial Report
5th Dec 201310:09 amRNSDirector/PDMR Shareholding
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSNewRiver acquires portfolio for retail conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.